Official Journal Health Science of Prince of Songkla University

  • Home
  • Search
  • Current
  • Archives
  • Announcements
  • Guide for Authors
  • Publication Ethics
  • Editorial Board
  • Submit
  • About
  • Contact
  • Online-first Articles
  • EVENTS
  • Review Process
  • Policies
Home > Online-first > Khikani
Cover Image

Expression of HCMV-Encoded miR-UL148D and miR-UL36-3P in Women with HCMV-Associated Miscarriage: A Case-Control Study

Ali Nadhim Shndiwe Khikani, Müge Fırat, Zaytoon Abdulrida Ighewish Al-Khafaji, Alyaa H. Alghrairi

Abstract

Objectives: To evaluate the expression levels of HCMV-encoded miR-UL148D and miR-UL36-3P in women with a miscarriage associated with HCMV infection.
Material and Methods: A case-control study was designed to include 50 women who had miscarriages due to active human cytomegalovirus (HCMV) infection, with a high HCMV viral load >10×10³ copies/mL, and a control group consisting of 50 healthy pregnant women who had not previously experienced miscarriages. RNAs were extracted from buffy coat samples to measure the HCMV-miR-UL148D and HCMV-miR-UL36-3P gene expression by the quantitative reverse transcription PCR (qRT-PCR) technique.
Results: Both HCMV-miR-UL148D and HCMV-miR-UL36-3P were significantly upregulated in miscarriage patients (2.66-fold and 21.16-fold changes, respectively; p-value<0.001). ROC analysis demonstrated strong diagnostic performance. For HCMV-miR-UL148D, sensitivity was 96%, and specificity was 98% (AUC=0.94). For HCMV-miR-UL36-3P, sensitivity was 91%, and specificity was 87% (AUC=0.94).
Conclusion: Elevated expressions of HCMV-encoded miR-UL148D and miR-UL36-3P may contribute to HCMV-associated miscarriage and could serve as potential biomarkers for adverse pregnancy outcomes.

 Keywords

gene expression; human cytomegalovirus; miscarriage; miR-UL148D; miR-UL36-3P

 Full Text:

PDF (Early Version)

References

Sijmons S, Van Ranst M, Maes P. Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencing. Viruses 2014;6:1049-72. doi: 10.3390/v6031049.

Qader SM, Al-Azzawy MA, Tawfiq SK. Possible roles of human cytomegalovirus immunoglobulin G and its avidity to specific human cytomegalovirus antigens in the prevention of abortion among pregnant women. Med J Babylon 2023;20:S41-7. doi: 10.4103/MJBL.MJBL_368_22.

Wang C, Biddison LD, Arafat D, Chaudhury S, Zhao L, Kim H, et al. Congenital cytomegalovirus infection: recent advances in understanding viral transmission, pathogenesis, and potential intervention strategies. J Clin Med 2024;13:640. doi: 10.3390/jcm13020640.

Syggelou A, Iacovidou N, Kloudas S, Christoni Z, Papaevangelou V. Congenital cytomegalovirus infection. Ann N Y Acad Sci 2010;1205:144-7. doi: 10.1111/j.1749-6632.2010.05649.x.

Dupont L, Reeves MB. Cytomegalovirus latency and reactivation: recent insights into an age-old problem. Rev Med Virol 2016;26:75-89. doi: 10.1002/rmv.1862.

Nigro G, Muselli M, CCVC Group. Prevention of congenital cytomegalovirus infection: review and case series of valaciclovir versus hyperimmune globulin therapy. Viruses 2023;15:1376. doi: 10.3390/v15061376.

Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 2007;23:243-9.

Duca M. MicroRNAs as targets for small-molecule binders. In: RNA as a drug target: next frontiers in medicinal chemistry. 2024:119-50. doi: 10.1002/9783527840458.ch6.

Khikani AN, Firat M, Al-Khafaji ZA. Association of HCMV-miR-UL36-5P gene expression with miscarriages in women with human cytomegalovirus infection in Babylon, Iraq. Al-Rafidain J Med Sci 2024;7:43-8. doi: 10.54133/ajms.v7i2.1363.

SAS Institute Inc. Statistical analysis system (SAS), version 9: user’s guide. Cary (NC): SAS Institute Inc.; 2012.

Kim Y, Lee S, Kim S, Kim D, Ahn JH, Ahn K. Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog 2012;8:e1002577. doi: 10.1371/journal.ppat.1002577.

Pan Y, Zhang Y, Jia Y, et al. Circulating human cytomegalovirus-encoded HCMV-miR-US4-1 as an indicator for predicting the efficacy of IFNα treatment in chronic hepatitis B patients. Sci Rep 2016;6:23007. doi: 10.1038/srep23007.

Ding M, Wang X, Wang Y, et al. Distinct expression profile of HCMV-encoded miRNAs in plasma from oral lichen planus patients. J Transl Med 2017;15:198. doi: 10.1186/s12967-017-1222-8.

Barbu MG, Condrat CE, Thompson DC, Bugnar OL, Cretoiu D, Toader OD, et al. MicroRNA involvement in signaling pathways during viral infection. Front Cell Dev Biol 2020;8:143. doi: 10.3389/fcell.2020.00143.

Babu SG, Pandey M, Shanmugam G, et al. Role of HCMV miR-UL70-3p and miR-UL148D in overcoming cellular apoptosis. Mol Cell Biochem 2014;393:89-98. doi: 10.1007/s11010-014-2049-8.

Pan C, Zhu D, Wang Y, et al. Human cytomegalovirus miR-UL148D facilitates latent viral infection by targeting host cell immediate early response gene 5. PLoS Pathog 2016;12:e1006007. doi: 10.1371/journal.ppat.1006007.

Diggins NL, Hancock MH. HCMV miRNA targets reveal important cellular pathways for viral replication, latency, and reactivation. Noncoding RNA 2018;4:29. doi: 10.3390/ncrna4040029.

Cheng S, Caviness K, Buehler J, et al. Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency. Proc Natl Acad Sci USA 2017;114:E10586-95. doi: 10.1073/pnas.17105221.

Lau B, Poole E, Krishna B, et al. Human cytomegalovirus miR-UL112-1 promotes down-regulation of viral immediate early gene expression during latency to prevent T-cell recognition of latently infected cells. J Gen Virol 2016;97:2387-98. doi: 10.1099/jgv.0.000546.

Gao Z, Zhou L, Bai J, Ding M, Liu D, Zheng S, et al. Assessment of HCMV-encoded microRNAs in plasma as potential biomarkers in pregnant women with adverse pregnancy outcomes. Ann Transl Med 2021;9:638. doi: 10.21037/atm-20-7354.

Zhou W, Li X, Wang X, et al. Different expression pattern of human cytomegalovirus-encoded microRNAs in circulation from virus latency to reactivation. J Transl Med 2020;18:1-13. doi: 10.1186/s12967-020-02653-w.

Al-Muswie RT, Enayah SH, Ghaleb RA. Synergistic effects of Cassia fistula extract combination with cisplatin on the regulation of microRNA-145 and gene expression in colon cancer cell line SW480. Med J Babylon 2023;20:670-80. doi: 10.4103/MJBL.MJBL_33_23.

Al-Khafaji ZAI, Firat M, Shndiwe AN. Evaluation of up-regulated miR-UL22A-3p gene expression in miscarriages women infected with human cytomegalovirus as biomarker for pregnancy complications. Microb Biosyst 2025;10:322165. doi: 10.21608/mb.2024.322165.1171.

Huang Y, Qi Y, Ma Y, et al. Down-regulation of human cytomegalovirus UL138, a novel latency-associated determinant, by HCMV-miR-UL36. J Biosci 2013;38:479-85. doi: 10.1007/s12038-013-9353-4.

Kim S, Lee S, Shin H, et al. Temporal landscape of microRNA-mediated host-virus crosstalk during productive human cytomegalovirus infection. Cell Host Microbe 2015;17:838-51. doi: 10.1016/j.chom.2015.05.014.

Golshan M, Yaghobi R, Geramizadeh B, Afshari A, Shahroodi JR, Malek-Hosseini SA. Determination of the importance of miR-UL148D gene expression pattern in cytomegalovirus infected transplant patients. Int J Org Transplant Med 2021;12:54.

DOI: http://dx.doi.org/10.31584/jhsmr.20261480

Refbacks

  • There are currently no refbacks.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SUBMIT A PAPER

JHSMR accepts online submission through

AHR-iCON 2026

About The Authors

Ali Nadhim Shndiwe Khikani orcid
Iraqi Ministry of Health, Babylon Health Directorate, Babylon,
Iraq

Müge Fırat orcid
Şabanözü Vocational High School, Veterinary Department, Çankırı Karatekin University, Ankara,
Turkey

Zaytoon Abdulrida Ighewish Al-Khafaji orcid
University of Babylon, Medicine College, Babylon,
Iraq

Alyaa H. Alghrairi orcid
Department of Microbiology, College of Medicine, University of Diyala, 32001, Ba’aqubah, Diyala,
Iraq

Article Tools
Abstract
Print this article
Indexing metadata
How to cite item
Email this article (Login required)
Email the author (Login required)

Journal Metrics

2023 (June)
Acceptance rate: 23.6%
2024 (June)
Acceptance rate: 19%
2025 (June)
Acceptance rate: 23%



Submission to final decision
74 days

Acceptance to publication
40 days


CiteScore Rank 2025

0.7
2025
CiteScore
 
32nd percentile
Q 3

JHSMR Facebook

JHSMR Facebook

Supported by

 

JHSMR now Indexed in








Image result for crossref





PSUMJ Homepage

Keywords COVID-19 SARS-CoV-2 Thailand Vietnam anxiety children depression diabetes diabetes mellitus elderly hypertension knowledge mental health mortality older adults prevalence quality of life reliability risk factors treatment validity
Journal Content

Browse
  • By Issue
  • By Author
  • By Title
Font Size

Open Journal Systems